Viewing Study NCT07022457

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:08 PM
Ignite Modification Date: 2026-03-28 @ 5:40 AM
Study NCT ID: NCT07022457
Status: RECRUITING
Last Update Posted: 2025-08-03
First Post: 2025-05-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: UK ENcorafenib and BInimetinib Real-world Study in Melanoma
Sponsor: Pierre Fabre Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma, BRAF V600 Mutation Positive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Melanoma View
None BRAF V600 View
None HRQoL View
None PROs View
None Encorafenib View
None Binimetinib View
None Real-World View
None prospective View